<?xml version="1.0" encoding="UTF-8"?>
<p id="Par31">Pancreatic ductal adenocarcinoma is often diagnosed at an advanced stage. Only 10â€“20% of patients present with resectable or borderline resectable pancreatic cancer, for which a potentially curative resection can be performed. Despite surgery, cure remains exceptional, as is demonstrated by a 10-year overall survival (OS) after resection of less than 4% [
 <xref ref-type="bibr" rid="CR1">1</xref>]. Most patients die of distant progression rather than local recurrence
 <bold>.</bold> Apparently, the vast majority of patients with local disease on imaging already have occult metastatic disease. This underlines the importance of systemic therapy.
</p>
